The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
MicroRNA‐377 is up‐regulated and can lead to increased fibronectin production in diabetic nephropathy
Open accessAbstract
Intrinsic glomerular cells in a diabetic milieu have transcriptional activation of genes that influence the development of diabetic nephropathy. The cellular repertoire of microRNAs can regulate translation of these expressed genes into proteins. Fibronectin is a key matrix protein accumulated in excess in diabetic nephropathy. Here, we exposed cultured human and mouse mesangial cells to high glucose and transforming growth factor‐β to simulate the diabetic milieu. In these conditions in vitro , as well as in mouse diabetic nephropathy models in vivo , microRNA‐377 was consistently up‐regulated relative to controls. Through a combination of computational and biological approaches, we identified relevant miR‐377 target genes. Although fibronectin was induced by miR‐377, it was not a direct target of miR‐377. However, miR‐377 led to reduced expressions of p21‐activated kinase and superoxide dismutase, which enhanced fibronectin protein production. Thus, overexpression of miR‐377 in diabetic nephropathy indirectly leads to increased fibronectin protein production;as such, miR‐377 can have a critical role in the pathophysiology of this prevalent human disease.— Wang, Q., Wang, Y., Minto, A. W., Wang, J., Shi, Q., Li, X., Quigg, R. J. MicroRNA‐377 is up‐regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 22, 4126–4135 (2008)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662
Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation
Vasudevan, S., Tong, Y., & Steitz, J. A. (2007) · Science · doi:10.1126/science.1149460 · Cited by 2,822
A pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 1×
“For example, miR-375 regulates insulin secretion in the pancreatic beta cell (26), which is further modulated by the effects of miR-124a and miR-96 on components of exocytosis pathways (27).”
BackgroundSaito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335
miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs
Mourelatos, Z., Dostie, J., Paushkin, S., Sharma, A., Charroux, B., Abel, L., Rappsilber, J., Mann, M., & Dreyfuss, G. (2002) · Genes & Development · doi:10.1101/gad.974702 · Cited by 1,105 · cited 1×
“MicroRNAs stably bind the 3 -untranslated regions (UTRs) of their target mRNAs when there is identity within their first 8 bases (6, 7).”
BackgroundMolecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Sheetz, M. J. (2002) · JAMA · doi:10.1001/jama.288.20.2579 · Cited by 1,002
Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J. J., & Natarajan, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611192104 · Cited by 699
Extracellular Matrix Metabolism in Diabetic Nephropathy
Mason, R. M., & Wahab, N. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065640.77499.d7 · Cited by 655
p21-activated kinases in cancer
Kumar, R., Gururaj, A. E., & Barnes, C. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1892 · Cited by 604
A New Method for Large Scale Isolation of Kidney Glomeruli from Mice
Takemoto, M., Asker, N., Gerhardt, H., Lundkvist, A., Johansson, B. R., Saito, Y., & Betsholtz, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64239-3 · Cited by 516
PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling
Lin, X., Duan, X., Liang, Y.-Y., Su, Y., Wrighton, K. H., Long, J., Hu, M., Davis, C. M., Wang, J., Brunicardi, F. C., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.044 · Cited by 485
Self-citationSuperoxide dismutases and their impact upon human health
Johnson, F., & Giulivi, C. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.006 · Cited by 467
High-Glucose–Triggered Apoptosis in Cultured Endothelial Cells
Baumgartner-Parzer, S. M., Wagner, L., Pettermann, M., Grillari, J., Gessl, A., & Waldhäusl, W. (1995) · Diabetes · doi:10.2337/diab.44.11.1323 · Cited by 354
Wang, Q., Li, Y. C., Wang, J., Kong, J., Qi, Y., Quigg, R. J., & Li, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800178105 · Cited by 350
Self-citationLocked nucleic acid-based in situ detection of microRNAs in mouse tissue sections
Obernosterer, G., Martinez, J., & Alenius, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.153 · Cited by 327
TGF-β signal transduction and mesangial cell fibrogenesis
Schnaper, H. W., Hayashida, T., Hubchak, S. C., & Poncelet, A.-C. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00300.2002 · Cited by 311
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Zhang, Z., Sun, L., Wang, Y., Ning, G., Minto, A. W., Kong, J., Quigg, R. J., & Li, Y. C. (2008) · Kidney International · doi:10.1038/sj.ki.5002572 · Cited by 305
Self-citationPAK and other Rho-associated kinases – effectors with surprisingly diverse mechanisms of regulation
ZHAO, Z.-S., & MANSER, E. (2005) · Biochemical Journal · doi:10.1042/bj20041638 · Cited by 293
PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation
Slack-Davis, J. K., Eblen, S. T., Zecevic, M., Boerner, S. A., Tarcsafalvi, A., Diaz, H. B., Marshall, M. S., Weber, M. J., Parsons, J. T., & Catling, A. D. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212141 · Cited by 279
Superoxide dismutase--applications and relevance to human diseases.
Noor, R., Mittal, S., & Iqbal, J. (2002) · PubMed · Cited by 271
Lovis, P., Gattesco, S., & Regazzi, R. (2008) · bchm · doi:10.1515/bc.2008.026 · Cited by 257
Renal disease and hypertension in non–insulin-dependent diabetes mellitus
Ismail, N., Becker, B., Strzelczyk, P., & Ritz, E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00232.x · Cited by 242
Substrate requirements for let-7 function in the developing zebrafish embryo
Kloosterman, W. P., Wienholds, E., Ketting, R. F., & Plasterk, R. H. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw173 · Cited by 221
Substrate requirements for let-7 function in the developing zebrafish embryo
Kloosterman, W. P. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh968 · Cited by 206
Stimulation of NFκB Activity by Multiple Signaling Pathways Requires PAK1
Frost, J. A., Swantek, J. L., Stippec, S., Yin, M. J., Gaynor, R., & Cobb, M. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909860199 · Cited by 189
microRNAs and the regulation of glucose and lipid metabolism
Poy, M. N., Spranger, M., & Stoffel, M. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00775.x · Cited by 186
The non-obese diabetic (NOD) mouse.
Leiter, E. H., Procházka, M., & Coleman, D. L. (1987) · PubMed · Cited by 182
Craven, P. A., Melhem, M. F., Phillips, S. L., & DeRubertis, F. R. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2114 · Cited by 158
High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism
Kang, B. P. S., Frencher, S. K., Reddy, V., Kessler, A., Malhotra, A., & Meggs, L. G. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00137.2002 · Cited by 156
Attenuation of Renal Injury in db/db Mice Overexpressing Superoxide Dismutase
DeRubertis, F. R., Craven, P. A., Melhem, M. F., & Salah, E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.762 · Cited by 143
Wu, D. T., Bitzer, M., Ju, W., Mundel, P. H., & Diaeresisttinger, E. P. B. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121055 · Cited by 132
Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy
Haneda, M., Koya, D., Isono, M., & Kikkawa, R. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000064500.89551.76 · Cited by 126
Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients
Ramakrishna, V., & Jailkhani, R. (2007) · Diagnostic Pathology · doi:10.1186/1746-1596-2-22 · Cited by 126
p21-activated Protein Kinase γ-PAK Suppresses Programmed Cell Death of BALB3T3 Fibroblasts
Jakobi, R., Moertl, E., & Koeppel, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007753200 · Cited by 113
Duan, X., Liang, Y.-Y., Feng, X., & Lin, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605169200 · Cited by 106
MEK1 activation by PAK: A novel mechanism
Park, E. R., Eblen, S. T., & Catling, A. D. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.01.018 · Cited by 98
Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol
DeRubertis, F. R., Craven, P. A., & Melhem, M. F. (2007) · Metabolism · doi:10.1016/j.metabol.2007.04.024 · Cited by 94
Uchimura, K., Nagasaka, A., Hayashi, R., Makino, M., Nagata, M., Kakizawa, H., Kobayashi, T., Fujiwara, K., Kato, T., Iwase, K., et al. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(99)00053-7 · Cited by 79
Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia.
Doi, T., Hattori, M., Agodoa, L. Y. C., Sato, T., Yoshida, H., Striker, L. J., & Striker, G. E. (1990) · PubMed · Cited by 71
Quigg, R. J., Morgan, B. P., Holers, V. M., Adler, S., Sneed, A. E., & Lo, C. (1995) · Kidney International · doi:10.1038/ki.1995.309 · Cited by 51
Self-citationLin, C.-L., Ho, C., Tung, C., Huang, W., Chang, P., Yang, J., & Wang, J.-Y. (2007) · American Journal of Nephrology · doi:10.1159/000111142 · Cited by 50
Self-citationCraven, P. A., Phillips, S. L., Melhem, M. F., Liachenko, J., & DeRubertis, F. R. (2001) · Metabolism · doi:10.1053/meta.2001.25802 · Cited by 49
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
MicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
Renal fibrosis: novel insights into mechanisms and therapeutic targets
Boor, P., Ostendorf, T., & Floege, J. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.120 · Cited by 606
TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1897 · Cited by 573
Suppression of microRNA-29 Expression by TGF-β1 Promotes Collagen Expression and Renal Fibrosis
Wang, B., Komers, R., Carew, R., Winbanks, C. E., Xu, B., Herman-Edelstein, M., Koh, P., Thomas, M., Jandeleit-Dahm, K., Gregorevic, P., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010055 · Cited by 498
Metadata
- Authors
- Wang, Q., Wang, Y., Minto, A. W., Wang, J., Shi, Q., Li, X., & Quigg, R. J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2008-08-20
- Volume
- 22
- Issue
- 12
- Pages
- 4126-4135
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2098365070
- Cited by
- 397
- References
- 44
- FWCI
- 16.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.